+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Formulation Development Outsourcing Market by Service Type, Dosage Form, Contract Model, Therapeutic Area - Global Forecast to 2030- Product Image
Formulation Development Outsourcing Market by Service Type, Dosage Form, Contract Model, Therapeutic Area - Global Forecast to 2030- Product Image
Sale

Formulation Development Outsourcing Market by Service Type, Dosage Form, Contract Model, Therapeutic Area - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666113
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Formulation Development Outsourcing Market grew from USD 43.76 billion in 2024 to USD 48.24 billion in 2025. It is expected to continue growing at a CAGR of 9.95%, reaching USD 77.34 billion by 2030.

Pioneering the Future of Formulation Development Outsourcing

The outsourcing of formulation development has emerged as a critical enabler for pharmaceutical and biotechnology companies striving to accelerate product pipelines and enhance operational efficiency. As internal R&D budgets face increasing scrutiny, leveraging the specialized capabilities of third-party development partners offers a pathway to mitigate risk, reduce time to market, and ensure regulatory compliance. This executive summary distills key findings from an in-depth analysis of service models, dosage form innovations, contractual frameworks, and therapeutic focus areas that define the current market.

Across every stage of the development continuum-from initial pre-formulation studies through analytical method validation and stability testing-outsourcing alliances have proven instrumental in unlocking scientific versatility and cost discipline. The insights presented here are grounded in robust primary interviews with industry executives and a meticulous review of secondary data sources, providing a holistic view of market dynamics. Readers will gain a clear understanding of the transformative shifts underway, the impact of new trade policies, and the competitive factors shaping provider differentiation. By synthesizing segmentation and regional nuances alongside strategic recommendations, this summary equips decision-makers with the perspective needed to confidently navigate the evolving outsourcing ecosystem.

Transformative Shifts Reshaping the Development Landscape

Innovation drivers such as advanced biologics, personalized medicine, and digitalization have catalyzed a rapid redefinition of the formulation development landscape. The proliferation of complex modalities, including mRNA and gene therapies, demands an agile partner ecosystem capable of scaling novel processes and ensuring rigorous quality controls. In parallel, AI-enabled formulation design tools and digital twins are accelerating early-stage decision-making, reducing experimental cycles, and optimizing excipient selection.

Regulatory agencies around the globe are harmonizing guidelines for generic and biosimilar submissions, prompting organizations to seek specialized regulatory filing support alongside their core development services. This convergence of technological advancement and evolving regulatory frameworks is fueling strategic shifts among contract service providers-driving expanded service portfolios, facility investments, and cross-border collaborations. As a result, the outsourcing market is witnessing a transformation in value proposition, with clients prioritizing integrated service models that deliver end-to-end capabilities under a single strategic partnership.

Unpacking the Full Impact of US Tariffs Rolling Out in 2025

The introduction of new United States tariffs in 2025 has introduced a layer of complexity to global sourcing strategies for raw materials, active pharmaceutical ingredients, and laboratory instrumentation. These cumulative levies on key chemical inputs and specialized equipment have exerted upward pressure on operational costs, compelling many development service providers to reassess supply chain resilience and contract pricing models. In response, leading organizations have accelerated nearshoring initiatives to mitigate tariff exposure while protecting project timelines.

Unveiling Core Segmentation Insights Driving Service Demand

A nuanced analysis of market demand reveals that the full spectrum of formulation development outsourcing services can be categorized by service type, dosage form, contract model, and therapeutic focus. Within service type, analytical development commands significant attention, driven by rigorous method development, validation, and sample analysis requirements, while formulation development and pre-formulation services remain critical for dosage optimization. Regulatory filing support and stability studies further anchor project lifecycles, ensuring seamless progress from bench to submission.

In terms of dosage form, the market extends from inhalation platforms and oral liquids to oral solids, with parenteral delivery mechanisms-including intramuscular, intravenous, and subcutaneous administration-accounting for premium service lines. Topical modalities such as creams, gels, and ointments coexist with transdermal systems, underscoring the importance of physicochemical expertise across diverse formulation challenges. Contract models range from fixed-price agreements that offer budgeting certainty to risk-sharing arrangements aligned with milestone achievements, as well as time-and-materials frameworks that provide flexible resource allocation. Finally, therapeutic area demand spans cardiovascular treatments, central nervous system interventions, infectious disease management, metabolic disorder solutions, and a robust oncology pipeline, each with unique developmental and regulatory intricacies that dictate specialized outsourcing requirements.

Regional Dynamics Fueling Growth Across Key Markets

Regional dynamics play a pivotal role in shaping market opportunities and operational strategies for formulation development outsourcing. In the Americas, a mature ecosystem supported by established biopharma hubs has fostered intense competition among contract providers, driving investments in high-throughput analytical capabilities and automation. Emerging biotech clusters in Mexico and Brazil are also gaining traction, positioning the region as a dual market of innovation and cost optimization.

Across Europe, the Middle East, and Africa, regulatory harmonization efforts and the push for biosimilar adoption have fueled demand for integrated development services. Providers are expanding networks of specialized facilities to serve Western European markets while exploring partnerships in the Middle East and North Africa to support localized product registrations. Meanwhile, the Asia-Pacific landscape is characterized by rapid capacity expansion in countries such as China and India, where favorable cost structures and growing domestic R&D engines are creating new outsourcing epicenters. Australia and Japan remain important sources of cutting-edge formulation science, contributing to a diverse regional mosaic of technical expertise and market potential.

Competitive Landscape and Strategic Positioning of Leading Providers

Competitive intensity among leading contract development organizations is at an all-time high, with top providers deploying strategic initiatives to secure differentiation. Catalent’s investment in continuous manufacturing platforms and advanced oral solid technologies underscores its commitment to accelerating complex product timelines. Thermo Fisher Scientific’s integrated model, spanning early-stage discovery through late-stage commercialization, reflects a trend toward fully orchestrated service offerings. Lonza’s focus on innovative drug delivery systems, alongside Recipharm’s expansion into biologics formulation, illustrates the ongoing convergence of capabilities across modalities.

Meanwhile, emerging players are forging alliances and making targeted acquisitions to bolster niche competencies, particularly in inhalation and transdermal technologies. Providers based in Asia are broadening their footprint in Western markets, leveraging cost competitiveness and local expertise to attract global clients. Strategic joint ventures between regional specialists and multinational firms are further diversifying the competitive landscape, enabling swift entry into high-growth segments and new geographies.

Actionable Strategies for Industry Leaders to Stay Ahead

Leaders in the pharmaceutical and biotechnology sectors should pursue a multifaceted approach to maximize the benefits of formulation development outsourcing. First, establishing long-term strategic alliances with a select group of partners that offer comprehensive service suites will enhance operational agility and knowledge transfer. Second, investing in collaborative digital platforms can streamline project management and enable real-time data sharing, thereby reducing cycle times and increasing visibility across global supply chains.

Furthermore, companies should proactively assess emerging contract models, including outcome-oriented risk-sharing agreements that align incentives and foster joint accountability. Maintaining flexibility in dosage form strategies-by partnering with providers experienced in both small-molecule and biologics domains-will safeguard against modality-specific bottlenecks. Finally, integrating tariff mitigation into procurement planning and exploring alternative sourcing corridors will protect cost structures from future trade disruptions, ensuring continuity in development timelines and budgetary predictability.

Rigorous Research Methodology Underpinning Insights

The insights presented in this report are grounded in a rigorous, multi-tiered research methodology designed to ensure analytical integrity and real-world relevance. Primary research included in-depth interviews with senior executives, R&D directors, and supply chain managers at leading pharmaceutical and contract development organizations. These qualitative discussions provided firsthand perspectives on strategic priorities, operational challenges, and partnership models.

Secondary research encompassed a thorough review of industry publications, regulatory filings, patent landscapes, and corporate disclosures. Data triangulation techniques were applied to validate market trends and pricing dynamics, while thematic analysis facilitated the identification of emerging service models and technology adoption patterns. The combined insights were synthesized into a cohesive framework that captures segmentation, regional variations, and competitive positioning without reliance on forecasted figures, thereby delivering a fact-based assessment of the current landscape.

Conclusive Perspectives on Outsourcing’s Strategic Imperative

In conclusion, the formulation development outsourcing market stands at the intersection of technological innovation, regulatory evolution, and shifting trade policies. Providers that successfully integrate advanced analytical capabilities, digital tools, and specialized modality expertise are best positioned to capture expanding demand across a spectrum of therapeutic areas. Regional variances present both opportunities and challenges, requiring tailored strategies that balance cost efficiencies with proximity to key markets.

As tariff changes introduce new considerations for supply chain design and service costing, organizations must adopt proactive procurement and partnership frameworks to navigate this evolving environment. By synthesizing segmentation insights with competitive analysis and actionable recommendations, decision-makers can confidently align their outsourcing strategies with broader corporate objectives. The strategic imperative is clear: embracing integrated, collaborative relationships with development partners will be the defining factor in accelerating product innovation and driving sustainable growth.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Service Type
    • Analytical Development
      • Method Development
      • Method Validation
      • Sample Analysis
    • Formulation Development
    • Pre Formulation
    • Regulatory Filing Support
    • Stability Studies
  • Dosage Form
    • Inhalation
    • Oral Liquid
    • Oral Solid
    • Parenteral
      • Intramuscular
      • Intravenous
      • Subcutaneous
    • Topical
      • Cream
      • Gel
      • Ointment
    • Transdermal
  • Contract Model
    • Fixed Price
    • Risk Sharing
    • Time And Materials
  • Therapeutic Area
    • Cardiovascular
    • Central Nervous System
    • Infectious Diseases
    • Metabolic Disorders
    • Oncology
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Samsung Biologics Co., Ltd.
  • Recipharm AB
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Siegfried Holding AG
  • Jubilant Life Sciences Limited
  • PCI Services LLC
  • Aenova Holding GmbH

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Formulation Development Outsourcing Market, by Service Type
8.1. Introduction
8.2. Analytical Development
8.2.1. Method Development
8.2.2. Method Validation
8.2.3. Sample Analysis
8.3. Formulation Development
8.4. Pre Formulation
8.5. Regulatory Filing Support
8.6. Stability Studies
9. Formulation Development Outsourcing Market, by Dosage Form
9.1. Introduction
9.2. Inhalation
9.3. Oral Liquid
9.4. Oral Solid
9.5. Parenteral
9.5.1. Intramuscular
9.5.2. Intravenous
9.5.3. Subcutaneous
9.6. Topical
9.6.1. Cream
9.6.2. Gel
9.6.3. Ointment
9.7. Transdermal
10. Formulation Development Outsourcing Market, by Contract Model
10.1. Introduction
10.2. Fixed Price
10.3. Risk Sharing
10.4. Time and Materials
11. Formulation Development Outsourcing Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular
11.3. Central Nervous System
11.4. Infectious Diseases
11.5. Metabolic Disorders
11.6. Oncology
12. Americas Formulation Development Outsourcing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Formulation Development Outsourcing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Formulation Development Outsourcing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Catalent, Inc.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Lonza Group AG
15.3.4. Samsung Biologics Co., Ltd.
15.3.5. Recipharm AB
15.3.6. Vetter Pharma-Fertigung GmbH & Co. KG
15.3.7. Siegfried Holding AG
15.3.8. Jubilant Life Sciences Limited
15.3.9. PCI Services LLC
15.3.10. Aenova Holding GmbH
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET MULTI-CURRENCY
FIGURE 2. FORMULATION DEVELOPMENT OUTSOURCING MARKET MULTI-LANGUAGE
FIGURE 3. FORMULATION DEVELOPMENT OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METHOD VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SAMPLE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGULATORY FILING SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STABILITY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL SOLID, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY OINTMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FIXED PRICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY RISK SHARING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TIME AND MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 58. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 59. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 60. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 61. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 62. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 63. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 64. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 66. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 67. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 68. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 69. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 70. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 100. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 101. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 102. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 103. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 104. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 105. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 106. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 107. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 108. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 109. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 110. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 111. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 112. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 113. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 121. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 122. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 123. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 124. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 125. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 126. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 127. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 128. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 130. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 131. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 132. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 133. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 134. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 144. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 145. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 146. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 147. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 148. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 151. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 152. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 153. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 154. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 155. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 156. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 157. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 158. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 159. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 160. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 161. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 162. DENMARK FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 170. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 171. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 172. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 173. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 174. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 175. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 176. QATAR FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 177. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 178. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 179. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 180. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 181. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 182. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 183. FINLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 186. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 187. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 188. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 189. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 190. SWEDEN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 193. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 194. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 195. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 196. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 197. NIGERIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 198. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 199. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 200. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 201. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 202. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 203. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 204. EGYPT FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 205. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 206. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 207. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 208. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 209. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 210. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 211. TURKEY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 219. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 220. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 221. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 222. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 223. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 224. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 225. NORWAY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 226. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 227. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 228. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 229. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 230. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 231. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 232. POLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 235. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 236. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 237. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 238. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 239. SWITZERLAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 248. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 249. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 250. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 251. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 252. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 253. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 254. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 255. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 256. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 257. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 258. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 259. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 260. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 261. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 262. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 263. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 264. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 265. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 266. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 267. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 268. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 279. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 280. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 281. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 282. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 287. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 288. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2030 (USD MILLION)
TABLE 289. INDONESIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 290. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 291. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 292. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 293. THAILAND FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 294. THAILAN

Companies Mentioned

The companies profiled in this Formulation Development Outsourcing market report include:
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Samsung Biologics Co., Ltd.
  • Recipharm AB
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Siegfried Holding AG
  • Jubilant Life Sciences Limited
  • PCI Services LLC
  • Aenova Holding GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 48.24 Billion
Forecasted Market Value ( USD ) by 2030 $ 77.34 Billion
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Formulation Development Outsourcing Market Size, Share & Trends Analysis Report by Service (Preformulation, Formulation Development), Formulation, Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Formulation Development Outsourcing Market Size, Share & Trends Analysis Report by Service (Preformulation, Formulation Development), Formulation, Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Chemistry, Manufacturing And Control Services Outsourcing Market Size, Share & Trends Analysis Report By Type, By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Chemistry, Manufacturing And Control Services Outsourcing Market Size, Share & Trends Analysis Report By Type, By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Global Formulation Development Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Formulation Development Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 164 Pages
  • Global
From
Formulation Development Outsourcing - Global Strategic Business Report - Product Image

Formulation Development Outsourcing - Global Strategic Business Report

  • Report
  • 84 Pages
  • Global
From
Pharmaceutical Services Outsourcing Market by Service Type, Clinical Phase, Customer Type, Contract Model, Therapeutic Area - Global Forecast to 2030 - Product Image

Pharmaceutical Services Outsourcing Market by Service Type, Clinical Phase, Customer Type, Contract Model, Therapeutic Area - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From

About the Formulation Development Market

The Formulation Development market within the context of Pharmaceutical Manufacturing is a specialized sector of the industry that focuses on the development of drug formulations. This includes the process of creating a drug product that is suitable for its intended use, such as a tablet, capsule, or injectable. This process involves the selection of the active pharmaceutical ingredient, the selection of excipients, the design of the formulation, and the optimization of the manufacturing process. The goal of this process is to create a safe and effective drug product that meets the requirements of regulatory agencies. Formulation Development is a critical step in the drug development process, as it ensures that the drug product is safe and effective. It is also important for the successful commercialization of a drug product. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.